SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 103 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $16,000 | 0.0% | 17,085 | +23.8% | 0.00% | – |
| Q1 2022 | $16,000 | -81.6% | 13,804 | -48.1% | 0.00% | – |
| Q4 2021 | $87,000 | -84.8% | 26,603 | -79.2% | 0.00% | – |
| Q3 2021 | $571,000 | -24.2% | 127,710 | -7.5% | 0.00% | – |
| Q2 2021 | $753,000 | -13.2% | 138,135 | +19.0% | 0.00% | – |
| Q1 2021 | $868,000 | +45.4% | 116,098 | +111.0% | 0.00% | – |
| Q4 2020 | $597,000 | – | 55,026 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|